Related Experiment Videos
Does short-term antiepileptic drug treatment in children result in cognitive or behavioral changes?
J Williams1, S Bates, M L Griebel
1University of Arkansas for Medical Sciences, Department of Pediatrics, and Arkansas Children's Hospital, Little Rock 72202, USA.
Insights
Antiepileptic drug (AED) therapy did not show significant cognitive or behavioral effects in children during the first six months of treatment. A comparison group with diabetes mellitus also showed no differences, suggesting AEDs are safe in the short term.
Area of Science:
- Pediatric Neurology
- Neuropsychology
Background:
- Epilepsy affects children, requiring treatment with antiepileptic drugs (AEDs).
- Potential cognitive and behavioral side effects of AEDs necessitate careful evaluation.
Purpose of the Study:
- To assess cognitive and behavioral effects of newly initiated AED therapy in children with epilepsy.
- To compare these effects against a control group with diabetes mellitus (DM).
Main Methods:
- Neuropsychological assessments were conducted on children with epilepsy (n=37) and a control group with DM (n=26).
- Participants were reevaluated after 6 months, with epilepsy patients achieving therapeutic AED levels and seizure control.
- Statistical analysis used ANCOVA to compare groups, controlling for baseline scores.
Main Results:
- No significant differences were observed between the AED and control groups in attention, memory, motor speed, or behavior problems.
- Specific p-values indicated no statistically significant group differences for any measured cognitive or behavioral factor.
Conclusions:
- AED monotherapy in children with newly diagnosed epilepsy did not produce detectable cognitive or behavioral adverse effects within the initial 6 months.
- While long-term AED treatment may have associated risks, short-term use appears safe regarding these specific outcomes.
Purpose:
To determine possible cognitive and behavioral effects of antiepileptic drug (AED) therapy by assessing children with newly diagnosed epilepsy before and after initiation of treatment. A comparison group of children with diabetes mellitus (DM) was included to control for the effects of practice, maturation, and chronic illness.
Methods:
Baseline neuropsychological assessments were completed for children with epilepsy (n = 37) and children with DM (n = 26) recruited through outpatient clinics at a regional children's hospital. Children were reevaluated 6 months from baseline testing. At follow-up, children with epilepsy had therapeutic AED levels and controlled seizures. Statistical analysis included a between-group repeated measures ANCOVA with pretest scores serving as the covariate.
Results:
Significant differences between groups were not found for any cognitive or behavioral factors, including attention (p < 0.24), immediate memory (p < 0.24), delayed memory (p < 0.10), complex motor speed (p < 0.19), or behavior problems (p < 0.89).
Conclusions:
Changes in performance on cognitive and behavioral measures were not different for children treated with AEDs and controls. Although adverse effects may be associated with prolonged treatment, results would not suggest adverse effects from AED monotherapy during the first 6 months of therapy.